Allen T Hopper

age ~59

from Lexington, MA

Get Report

Also known as:

Connected to:

Allen Hopper Phones & Addresses

Glyt-1 Inhibitors
view source
US Patent:

6667336, Dec 23, 2003
Filed:

Feb 15, 2002
Appl. No.:

10/077579
Inventors:

Zhaoqing Wang - Greenwood IN
William Delaney - Bear DE
Ashok Tehim - Ridgewood NJ
Shawn Maddaford - Mississauga, CA
Ian Egle - Mississauga, CA
Richard Schumacher - Monroe NY
Allen T. Hopper - Glen Rock NJ
Assignee:

NPS Allelix Corp. - Mississauga
Allelix Neuroscience, Inc. - Salt Lake City UT
International Classification:

A61K 3138
US Classification:

514444, 514438, 549 77, 549 59
Abstract:

The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof.

Phosphodiesterase 4 Inhibitors
view source
US Patent:

6699890, Mar 2, 2004
Filed:

Jan 22, 2002
Appl. No.:

10/051309
Inventors:

Richard A. Schumacher - Monroe NY
William F. Brubaker - Cheshire CT
Michael De Vivo - New York NY
Allen Hopper - Glen Rock NJ
Ashok Tehim - Ridgewood NJ
Ruiping Liu - Huntington NY
Axel Unterbeck - Madison CT
Assignee:

Memory Pharmaceuticals Corp. - Montvale NJ
International Classification:

C07D21340
US Classification:

514352, 514381, 514247, 514315, 514374, 514360, 546194, 546304, 549 13, 549200, 549229
Abstract:

PDE4 inhibition is achieved by novel compounds, e. g. , N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R , R , R and R are as defined herein.

Phosphodiesterase 4 Inhibitors
view source
US Patent:

7087625, Aug 8, 2006
Filed:

Nov 19, 2003
Appl. No.:

10/715819
Inventors:

Richard A. Schumacher - Monroe NY, US
Elizabeth Doorly Graham - River Vale NJ, US
Allen T. Hopper - Glen Rock NJ, US
Ashok Tehim - Ridgewood NJ, US
Assignee:

Memory Pharmaceuticals Corporation - Montvale NJ
International Classification:

C07D 213/02
C07D 419/12
A61K 31/44
US Classification:

514337, 514338, 514357, 5462757, 5462834, 546546, 546334
Abstract:

PDE4 inhibition is achieved by novel nitroxide compounds, e. g. , N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formulas I–III:.

Phosphodiesterase 4 Inhibitors, Including Aminoindazole And Aminobenzofuran Analogs
view source
US Patent:

7153871, Dec 26, 2006
Filed:

Jul 18, 2003
Appl. No.:

10/622117
Inventors:

Richard A. Schumacher - Monroe NY, US
Allen T. Hopper - Glen Rock NJ, US
Ashok Tehim - Ridgewood NJ, US
Assignee:

Memory Pharmaceuticals Corporation - Montvale NJ
International Classification:

C07D 405/12
C07D 405/14
A61K 31/443
A61K 31/4439
C07D 401/12
US Classification:

514337, 514470, 5462684, 5462841, 549467
Abstract:

PDE4 inhibition is achieved by novel compounds, e. g. , aminoindazole and aminobenzofuran analogs. The compounds of the present invention are of Formulas I and II:.

Phosphodiesterase 4 Inhibitors
view source
US Patent:

7205320, Apr 17, 2007
Filed:

Jan 12, 2004
Appl. No.:

10/754600
Inventors:

Richard A. Schumacher - Monroe NY, US
William F. Brubaker - Cheshire CT, US
Michael De Vivo - New York NY, US
Hans-Jürgen Ernst Hess - Old Lyme CT, US
Allen Hopper - Glen Rock NJ, US
Ashok Tehim - Ridgewood NJ, US
Ruiping Liu - Huntington NY, US
Axel Unterbeck - Madison CT, US
Assignee:

Memory Pharmaceuticals Corp. - Montvale NJ
International Classification:

A61K 31/4406
A61K 31/4439
C07D 213/38
C07D 401/12
US Classification:

514340, 5142521, 514357, 514367, 514374, 514438, 514471, 544409, 5462684, 546337, 548179, 548237, 549 75, 549451
Abstract:

PDE4 inhibition is achieved by novel compounds, e. g. , N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I:.

Phosphodiesterase 4 Inhibitors
view source
US Patent:

7226930, Jun 5, 2007
Filed:

Apr 16, 2004
Appl. No.:

10/825611
Inventors:

Allen Hopper - Glen Rock NJ, US
Erik Kuester - Franklin NJ, US
Robert Dunn - Towaco NJ, US
Richard Conticello - Ossining NY, US
Assignee:

Memory Pharmaceutical Corporation - Montvale NJ
International Classification:

A61K 31/437
A61K 31/4155
C07D 231/54
C07D 471/06
US Classification:

514303, 514406, 546119, 5483611
Abstract:

Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.

Phosphodiesterase 4 Inhibitors
view source
US Patent:

7235579, Jun 26, 2007
Filed:

Oct 16, 2002
Appl. No.:

10/270724
Inventors:

Ruiping Liu - Huntington NY, US
Mike De Vivo - New York NY, US
Hans-Jurgen Ernst Hess - Old Lyme CT, US
Allen Hopper - Glen Rock NJ, US
Erik Kuester - Franklin NJ, US
Ashok Tehim - Ridgewood NJ, US
Assignee:

Memory Pharmaceuticals Corp. - Montvale NJ
International Classification:

A61K 31/40
C09D 409/00
US Classification:

514422, 548518, 548527
Abstract:

Selective PDE4 inhibition is achieved by 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds like rolipram and show selectivity with regard to inhibition of other classes of PDEs. The compounds of the present invention are of formula I: wherein R, R, and Rare as defined herein.

Heterocyclic Compounds, Methods For The Preparation Thereof, And Uses Thereof
view source
US Patent:

7244745, Jul 17, 2007
Filed:

Aug 29, 2003
Appl. No.:

10/651023
Inventors:

Brian Herbert - Stockholm NJ, US
Wenge Xie - Mahwah NY, US
Truc Minh Nguyen - New York NY, US
Allen T Hopper - Glen Rock NJ, US
Ashok Tehim - Ridgewood NJ, US
Assignee:

Memory Pharmaceuticals Corp. - Montvale NJ
International Classification:

C07D 401/02
A61K 31/44
US Classification:

514333, 514334, 546256, 546257
Abstract:

The compounds of the present invention are of formula I: wherein A, R, Ris as defined herein, are useful as ligands for nicotinic receptors.